Kathleen Tregoning
Direktor/Vorstandsmitglied bei SPERO THERAPEUTICS, INC.
Vermögen: 470 169 $ am 30.04.2024
Aktive Positionen von Kathleen Tregoning
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Public Communications Contact | 01.07.2020 | - |
| SPERO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.10.2021 | - |
| Independent Dir/Board Member | 11.10.2021 | - |
Karriereverlauf von Kathleen Tregoning
Ehemalige bekannte Positionen von Kathleen Tregoning
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANOFI | Public Communications Contact | 01.02.2017 | 01.03.2020 |
Biogen France SAS
 Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Corporate Officer/Principal | 01.01.2006 | - |
Ausbildung von Kathleen Tregoning
| Stanford University | Undergraduate Degree |
| Harvard Kennedy School of Government | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Frankreich | 3 |
Operativ
| Public Communications Contact | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SANOFI | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Kathleen Tregoning
- Erfahrung
